Fennec Pharmaceuticals (FENC) Cash from Operations (2016 - 2025)
Historic Cash from Operations for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to $1.5 million.
- Fennec Pharmaceuticals' Cash from Operations rose 16767.91% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 13384.34%. This contributed to the annual value of $27.0 million for FY2024, which is 25738.2% up from last year.
- Per Fennec Pharmaceuticals' latest filing, its Cash from Operations stood at $1.5 million for Q3 2025, which was up 16767.91% from -$3.7 million recorded in Q2 2025.
- In the past 5 years, Fennec Pharmaceuticals' Cash from Operations registered a high of $39.0 million during Q1 2024, and its lowest value of -$8.4 million during Q2 2024.
- Over the past 5 years, Fennec Pharmaceuticals' median Cash from Operations value was -$3.6 million (recorded in 2021), while the average stood at -$1.2 million.
- Within the past 5 years, the most significant YoY rise in Fennec Pharmaceuticals' Cash from Operations was 80014.34% (2024), while the steepest drop was 11254.43% (2024).
- Quarter analysis of 5 years shows Fennec Pharmaceuticals' Cash from Operations stood at -$3.0 million in 2021, then crashed by 129.95% to -$6.8 million in 2022, then grew by 28.55% to -$4.9 million in 2023, then soared by 69.67% to -$1.5 million in 2024, then skyrocketed by 201.29% to $1.5 million in 2025.
- Its Cash from Operations was $1.5 million in Q3 2025, compared to -$3.7 million in Q2 2025 and -$4.3 million in Q1 2025.